Acoramidis Hydrochloride

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameAcoramidis Hydrochloride
Drug Alias NameEidos Therapeutics AG10AG10 hydrochlorideAttrubyBeyonttraBBP-265 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransthyretin stabilizers
TargetsTransthyretin
Therapy Area/IndicationsTransthyretin amyloidosisAmyloidosisAmyloidosis, Familial +[8] 
Global Approved IndicationsTransthyretin amyloidosisAmyloid Neuropathies, Familial
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2024/11/22
Country/TerritoryCzechiaBelgiumCanada +[29] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesBridge Bio Europe BVBridgebio Pharma IncAlexion Pharmaceuticals Inc +[5] 
Inactive CompaniesN/A
Active IndicationsTransthyretin amyloidosisAmyloidosisAmyloidosis, Familial +[7] 
Inactive IndicationsAmyloid Neuropathies

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG